Each drug may be known by three or four, and often by more than . . . The term "brand name" is used here to refer to the name of the company that produces, packages, distributes or markets any ...

Since Viagra is a brand-name medication, the price of Viagra is very high and may not currently fit within your budget. But a generic version (and the active ingredient) of this popular medication ...

Eugene Hill, 31, admitted to a federal court in July that he sold oxycodone and marijuana to ... D.C., these laws only allow selling the drug in a regulated retail setting. Weed is still illegal ...

Meanwhile, AbbVie's lineup features other big winners. Sales for cancer drug Venclexta and antipsychotic medication Vraylar continue to climb. The company's migraine drugs, Qulipta and Ubrelvy ...

Exparel only comes as a brand-name drug. It’s not currently available in a generic version. A generic contains an exact copy of the active drug in a brand-name medication but tends to cost less.

Here are the most recent arrest reports and court results as provided by the Martinsville, Henry County and Patrick County ...

The rapidly expanding use of pill press machines has enabled lethal counterfeit pill manufacturing in neighborhoods across Massachusetts.

The company operates through Abbreviated New Drug ... release Oxycodone with Naltrexone; Loxapine Succinate capsules for treating antipsychotic under the Loxapine brand; Acetaminophen and Codeine ...

Plaquenil (hydroxychloroquine) is a brand-name oral tablet that’s prescribed for lupus, rheumatoid arthritis, and malaria. The cost of the drug, with and without insurance, can depend on several ...

Regardless of where you live in the U.S., chances are you stand in the grocery aisle, price-comparing generic items to name brand ones. You’re not alone, either. Private-label brand sales ...

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing ...

The average drug now costs more than US$1 billion to develop and takes more than a decade to reach the market 1. And for every success, there are nine drug candidates that fail clinical trials 2.